Abstract

To the Editor: We read with great interest the article by Gu et al,1 who compared the effects of intracoronary abciximab versus intravenous administration on myocardial reperfusion in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with thrombus aspiration. They found that intracoronary administration of abciximab, compared with intravenous administration, did not improve the rate of successful myocardial reperfusion, as …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.